Sonodynamic Therapy With ExAblate System in Glioblastoma Patients

NCT04845919 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: 5-Aminolevulinic Acid

Sponsor

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta